Biotechne share price
WebApr 14, 2024 · The company has a market cap of $13.14 billion, a PE ratio of 51.89, a price-to-earnings-growth ratio of 2.47 and a beta of 1.25. The company has a debt-to-equity … WebThe latest Bio-Techne Corp Ordinary USD0.01 share price. View recent trades and share price information for Bio-Techne Corp Ordinary USD0.01
Biotechne share price
Did you know?
WebApr 13, 2024 · MINNEAPOLIS, April 13, 2024 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced it will present its portfolio of products and solutions to advance cancer research and enable cell and gene therapy development and manufacturing at the upcoming annual meeting of the American Association for Cancer Research … WebApr 12, 2024 · The price-earnings ratio gauges market expectation of future performance by relating a stock’s current share price to its earnings per share. BIO-TECHNE Corp Stock Price History. BIO-TECHNE Corp’s price is currently up 9.48% so far this month. During the month of April, BIO-TECHNE Corp’s stock price has reached a high of $81.24 and a low ...
WebApr 11, 2024 · The company's stock saw significant share price movement during recent months on the NASDAQGS, rising to highs of US$86.62 and falling to the lows of US$71.62. Some share price movements can give ... WebApr 14, 2024 · The biotechnology company reported $0.38 earnings per share for the quarter, missing the consensus estimate of $0.41 by ($0.03). Bio-Techne had a return on …
WebConsensus Price Target is the stock price analysts expect to see within a period of 0-18 months. EPS and Revenue estimates are for the next 12 months. Markets data provided … WebThe average price target is $ 0.00 with a high estimate of $ 0.00 and a low estimate of $ 0.00. ... Whether you're buying your first share or investing for the long-haul, we have you covered ...
Web18 hours ago · About Price to Free Cash Flow. The Price to Free Cash Flow ratio or P/FCF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or ...
WebBased in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment makes equipment and associated consumables for ... orchidologistWebApr 9, 2024 · The biotechnology company reported $0.38 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.41 by ($0.03). Bio-Techne had a net margin of 23.38% and a return ... orchidophiles montrealWebMar 31, 2024 · Currently, BIO-TECHNE Corp’s price-earnings ratio is 46.2. BIO-TECHNE Corp’s trailing 12-month revenue is $1.1 billion with a 23.4% profit margin. Year-over-year quarterly sales growth most recently was 0.9%. Analysts expect adjusted earnings to reach $2.013 per share for the current fiscal year. BIO-TECHNE Corp currently has a 0.4% ... orchidopexeWebAug 5, 2024 · Delivered adjusted earnings per share (EPS) of $1.87 versus $1.00 one year ago. Full year GAAP EPS was $3.47 vs $5.82 one year ago. Full year adjusted EPS was $6.75 vs $4.55 in the prior year. ... the impact of the growing number of producers of biotechnology research products and related price competition, general economic … ira account rules withdrawal penaltyWebHistorical daily share price chart and data for Bio-Techne Corp since 1992 adjusted for ... ira account withdrawal ageWeb18 hours ago · About Price to Free Cash Flow. The Price to Free Cash Flow ratio or P/FCF is price divided by its cash flow per share. It's another great way to determine whether a … orchidopexie bdsWebApr 11, 2024 · Market capitalization is calculated by taking a company’s share price and multiplying it by the total number of shares. It’s often used to measure a company’s size. … ira account vanguard vs fidelity